Evidence map›Paper›PMID 27130231›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2016

Endothelin Receptor A Antagonism Prevents Damage to Glycogen-Rich Placental Cells Following Uterine Ischemia-Reperfusion in the Rat.

Larry G Thaete, Saira Khan, Mark G Neerhof

Open access · bronzeAbstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Larry G ThaeteDepartment of Obstetrics & Gynecology, NorthShore University HealthSystem, Evanston, IL, USA Department of Obstetrics & Gynecology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA Lthaete@northshore.org.
Saira KhanDepartment of Obstetrics & Gynecology, NorthShore University HealthSystem, Evanston, IL, USA Department of Pediatrics, University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
Mark G NeerhofDepartment of Obstetrics & Gynecology, NorthShore University HealthSystem, Evanston, IL, USA Department of Obstetrics & Gynecology, University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
NorthShore University HealthSystem · USUniversity of Chicago · US

Funding

ET and PAF Synergism in intrauterine growth restrictionR01HD042581 · NICHD · NORTHSHORE UNIV HEALTHSYSTEM RES INST · PI THAETE, LARRY G · 2004 to 2008
$1.2M
NICHD NIH HHS R01 HD042581
6 · The paper itself

Abstract

Fetal growth restriction (FGR) is a common cause of perinatal morbidity and mortality. Suboptimal uteroplacental perfusion is the most commonly identified cause of FGR, and ischemic lesions are often observed in placentas from pregnancies complicated by FGR. Ischemia followed by reperfusion is a strong stimulus to the production of the vasoconstrictor endothelin 1 (ET-1) which has been implicated in several models of FGR. We sought to investigate oxidative stress and placental morphology in a rat model of ischemia-reperfusion (I/R)-induced FGR and to evaluate the role of ET-1 in the observed pathology. Unilateral uterine I/R (30 min) was conducted, with and without simultaneous ET-1 receptor A (ET

Indexed as

AnimalsEndothelin A Receptor AntagonistsFemaleFetal Growth RetardationGlycogenIschemiaMaleNucleic AcidsOxidative StressPlacentaPregnancyPyrrolidinesRatsRats, Sprague-DawleyReperfusion InjuryUterusABT 546Endothelin A Receptor AntagonistsGlycogenNucleic AcidsPyrrolidinesendothelin receptor antagonistsischemiaoxidative stressplacentarats

Identifiers

PMID27130231
PMCPMC5933107
OpenAlexW2344046588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.